PALISADE BIO, INC. (PALI) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $264 million, PALISADE BIO, INC. is a micro-cap company. The stock currently trades at $1.81, up 2.54% today, with a 52-week range of $0.53–$2.64.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-10.19 | $-10.19 | -466.1% | |
| 2023 | $-1.80 | $-1.80 | +89.1% | |
| 2022 | $-16.53 | $-16.53 | -387.6% | |
| 2021 | $-3.39 | $-2.86 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-24 | 0000950170-25-043859 | SEC ↗ |
| 2023-12-31 | 2024-03-26 | 0000950170-24-036402 | SEC ↗ |
| 2022-12-31 | 2023-03-22 | 0000950170-23-009226 | SEC ↗ |
| 2021-12-31 | 2022-03-17 | 0000950170-22-004093 | SEC ↗ |
| 2020-12-31 | 2021-03-22 | 0001171843-21-001965 | SEC ↗ |
| 2019-12-31 | 2020-03-27 | 0001171843-20-002061 | SEC ↗ |
| 2018-12-31 | 2019-03-22 | 0001171843-19-001917 | SEC ↗ |
| 2017-12-31 | 2018-04-02 | 0001171843-18-002404 | SEC ↗ |
| 2016-12-31 | 2017-03-23 | 0001171843-17-001704 | SEC ↗ |
| 2015-12-31 | 2016-03-14 | 0001144204-16-087765 | SEC ↗ |
| 2014-12-31 | 2015-03-16 | 0001144204-15-016085 | SEC ↗ |
| 2013-12-31 | 2014-03-10 | 0001144204-14-014279 | SEC ↗ |
| 2012-12-31 | 2013-03-15 | 0001144204-13-015444 | SEC ↗ |
| 2011-12-31 | 2012-03-30 | 0001144204-12-018248 | SEC ↗ |
| 2010-12-31 | 2011-03-16 | 0001144204-11-015138 | SEC ↗ |